While Covid is at its highest in six months in China and the government is strengthening its “zero Covid” policy, the race for “homegrown” vaccines and drugs is not slowing down. China, which has 3 million cases and 16,000 Covid-related deaths to date, makes a point of promoting its own vaccines and treatments. At this stage, seven local vaccines are approved, including two major vaccines from Sinovac and Sinopharm. But as new, more virulent variants emerged, they proved less effective in terms of deaths and hospitalizations than Pfizer/BioNTech and Moderna.
- Prime Macron 2022: conditions, amount, payment date … how it works?
However, to date, no Chinese vaccine or booster specifically targeting Omicron has been approved in the country. Neither is a messenger RNA vaccine, although Chinese labs have been working on it for two years.
According to the GlobalData Institute, 10 Chinese messenger RNA vaccines are in clinical trials. While China has not confirmed any, Indonesia was the first…
This article is for subscribers only. You have 76% left to discover.
Black Friday
-70% on digital subscription
I ENJOYED
Already subscribed? enter
Source: Le Figaro
I’m Liza Grey, an experienced news writer and author at the Buna Times. I specialize in writing about economic issues, with a focus on uncovering stories that have a positive impact on society. With over seven years of experience in the news industry, I am highly knowledgeable about current events and the ways in which they affect our daily lives.